Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | TNF | P01375 | 1/20 | 0.38 |
| ▸ | CYSLTR2 | Q9NS75 | 3/20 | 0.37 |
| ▸ | CYSLTR1 | Q9Y271 | 3/20 | 0.37 |
| ▸ | LTA4H | P09960 | 6/20 | 0.37 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.37 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.37 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.37 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | MMP13 | P45452 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17164338 | 0.90 | MAPT (0.43) | BRD4TNFCYSLTR2CYSLTR1LTA4H | |
| SCHEMBL21943236 | 0.80 | BRD4 (0.41) | BRD4CYSLTR2CYSLTR1LTA4HPDK2 | |
| SCHEMBL25748409 | 0.80 | BRD4 (0.41) | BRD4CYSLTR2CYSLTR1LTA4HPDK2 | |
| SCHEMBL20522004 | 0.75 | MAPT (0.39) | PDE3BPDE3AP2RY12MAPT | |
| SCHEMBL29397620 | 0.73 | MAPT (0.43) | BRD4TNFPDE3BPDE3AP2RY12 | |
| SCHEMBL13490815 | 0.72 | BRD4 (0.47) | BRD4TNFCYSLTR2CYSLTR1LTA4H | |
| SCHEMBL4389091 | 0.71 | BRD4 (0.53) | BRD4CYSLTR2CYSLTR1LTA4HPDK2 | |
| SCHEMBL28108700 | 0.71 | PPARA (0.42) | CYSLTR2CYSLTR1MAPT | |
| SCHEMBL29198000 | 0.69 | BRD4 (0.51) | BRD4CYSLTR2CYSLTR1LTA4HPDK2 | |
| SCHEMBL20448215 | 0.68 | MAPT (0.38) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3356373-B1 | NOVEL MACROCYCLIC SULFONDIIMINE COMPOUNDS | Bayer Pharma AG (DE) | 2020-02-19 | — | — | EP | disclosed |
| EP-3129387-B1 | NOVEL MACROCYCLIC COMPOUNDS | Bayer Pharma AG (DE) | 2019-06-26 | — | — | EP | disclosed |
| WO-2017060322-A2 | PTEFB-INHIBITOR-ADC | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-04-13 | — | — | WO | disclosed |